Aravive, Inc.
ARAV · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $3 | $1 | $1 | $1 |
| % Growth | 116.3% | -14.6% | 1.2% | – |
| Cost of Goods Sold | $9 | $11 | $16 | $18 |
| Gross Profit | -$6 | -$10 | -$14 | -$16 |
| % Margin | -216.8% | -746.9% | -967.4% | -1,118% |
| R&D Expenses | $9 | $11 | $16 | $18 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $1 | $1 | -$9 |
| Operating Expenses | $12 | $14 | $19 | $21 |
| Operating Income | -$9 | -$13 | $15 | -$20 |
| % Margin | -323.4% | -987.9% | 1,025.8% | -1,347.6% |
| Other Income/Exp. Net | $30 | $31 | -$32 | -$9 |
| Pre-Tax Income | $21 | $18 | -$50 | -$29 |
| Tax Expense | $0 | $0 | $32 | $9 |
| Net Income | $21 | $18 | -$82 | -$38 |
| % Margin | 770.2% | 1,413.5% | -5,499.6% | -2,604.1% |
| EPS | 0.28 | 0.24 | -1.08 | -0.61 |
| % Growth | 16.7% | 122.2% | -77% | – |
| EPS Diluted | 0.28 | -0.12 | -1.08 | -0.61 |
| Weighted Avg Shares Out | 76 | 100 | 76 | 63 |
| Weighted Avg Shares Out Dil | 76 | 100 | 76 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $33 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$38 | -$42 | $16 | -$29 |
| % Margin | -1,376% | -3,293.3% | 1,040.2% | -1,975.8% |